相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges
Iria Seoane-Viano et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Translating 3D printed pharmaceuticals: From hype to real-world clinical applications
Iria Seoane-Viano et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release
Ni Dong et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
A once-monthly GLP-1 receptor agonist for treatment of diabetic cats
E. L. Schneider et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2020)
Novel strategy for oral peptide delivery in incretin-based diabetes treatment
Yining Xu et al.
GUT (2020)
Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
Nicholas G. Lamson et al.
NATURE BIOMEDICAL ENGINEERING (2020)
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
Karen L. Jones et al.
DIABETES OBESITY & METABOLISM (2020)
Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics
David S. Collins et al.
JOURNAL OF CONTROLLED RELEASE (2020)
A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type II diabetes
Zhiyu He et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide
P. Uhl et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
Christopher K. Rayner et al.
DIABETES CARE (2020)
Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice
Xiaoyan Bao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting
Giulia Di Dalmazi et al.
CLINICAL THERAPEUTICS (2020)
Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer
S. M. Jusu et al.
SCIENTIFIC REPORTS (2020)
Assisted 3D printing of microneedle patches for minimally invasive glucose control in diabetes
Mingxin Wu et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics
Junqiu Zhai et al.
DRUG DELIVERY (2020)
The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes
Mads Frederik Rasmussen
DIABETOLOGY INTERNATIONAL (2020)
Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency
Yina Song et al.
NANOMEDICINE (2019)
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Raffaella Gentilella et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Sustained Release of Exendin 4 Using Injectable and lonic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus
Bo-Bae Seo et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes
Zhiyu He et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery
Ruba Ismail et al.
PHARMACEUTICAL RESEARCH (2019)
Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features
Katherine A. Lyseng-Williamson
CLINICAL DRUG INVESTIGATION (2019)
Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
Bo Ahren
JOURNAL OF DIABETES INVESTIGATION (2019)
Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation
Aiping Wang et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2019)
Rationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide
Muhammad Mustafa Abeer et al.
PHARMACEUTICS (2019)
Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site
Iris Usach et al.
ADVANCES IN THERAPY (2019)
Sustained release and pharmacologic evaluation of human glucagon-like peptide-1 and liraglutide from polymeric microparticles
Luis Pena Icart et al.
JOURNAL OF MICROENCAPSULATION (2019)
Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System
Chune Zhu et al.
AAPS PHARMSCITECH (2019)
Effect of Stabilizers on Encapsulation Efficiency and Release Behavior of Exenatide-Loaded PLGA Microsphere Prepared by the W/O/W Solvent Evaporation Method
Heejun Park et al.
PHARMACEUTICS (2019)
Subcutaneous delivery of biotherapeutics: challenges at the injection site
Joana A. D. Sequeira et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model
Kenichi Suzuki et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
A. Arranz-Romera et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption
Yina Song et al.
MOLECULAR PHARMACEUTICS (2019)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Battle of GLP-1 delivery technologies
Minzhi Yu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Effects of the multilayer structures on Exenatide release and bioactivity in microsphere/thermosensitive hydrogel system
Puxiu Wang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
In vitro models for immunogenicity prediction of therapeutic proteins
Floriane Groell et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Nanoparticles induced by embedding self-assembling cassette into glucagon-like peptide 1 for improving in vivo stability
Ying Li et al.
FASEB JOURNAL (2018)
3D printed microneedles for insulin skin delivery
Cristiane Patricia Pissinato Pere et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
The use of low molecular weight protamine to enhance oral absorption of exenatide
Liping Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies
Hanne Kinnunen Bown et al.
JOURNAL OF CONTROLLED RELEASE (2018)
In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide
Claudia Menzel et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins
Michael R. Turner et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Long-Acting Release Microspheres Containing Novel GLP-1 Analog as an Antidiabetic System
Sida Ruan et al.
MOLECULAR PHARMACEUTICS (2018)
Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
Dilan Athauda et al.
NEUROPHARMACOLOGY (2018)
Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination
Rohiverth Guarecuco et al.
VACCINE (2018)
Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice
Yanan Shi et al.
SCIENTIFIC REPORTS (2018)
Exendin-4-encapsulated dissolving microneedle arrays for efficient treatment of type 2 diabetes
Shayan Fakhraei Lahiji et al.
SCIENTIFIC REPORTS (2018)
Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
Christina Neuner Boyle et al.
MOLECULAR METABOLISM (2018)
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Beate Bittner et al.
BIODRUGS (2018)
Development of chitosan coated calcium-alginate nanocapsules for oral delivery of liraglutide to diabetic patients
Fatemeh Shamekhi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Subcutaneous delivery of monoclonal antibodies: How do we get there?
Margarida Viola et al.
JOURNAL OF CONTROLLED RELEASE (2018)
The stimulation of GLP-1 secretion and delivery of GLP-1 agonists &ITvia&IT nanostructured lipid carriers
Neha Shrestha et al.
NANOSCALE (2018)
Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides
Sharad Kharel et al.
PHARMACEUTICAL RESEARCH (2018)
Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro-resistant microparticles
Liat Soudry-Kochavi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Chitosan-based thermosensitive hydrogel for nasal delivery of exenatide: Effect of magnesium chloride
Ying Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction
Noriyasu Kamei et al.
SCIENTIFIC REPORTS (2018)
The Discovery of Insulin: An Important Milestone in the History of Medicine
Ignazio Vecchio et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Hao Zhong et al.
PHARMACEUTICS (2018)
Albiglutide for the management of type 2 diabetes
Marc S. Rendell
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2018)
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Gitanjali Srivastava et al.
CURRENT OBESITY REPORTS (2018)
Glycosaminoglycans contribute to extracellular matrix fiber recruitment and arterial wall mechanics
Jeffrey M. Mattson et al.
BIOMECHANICS AND MODELING IN MECHANOBIOLOGY (2017)
Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(L-lysine) block copolymer: potential implications on diabetic nephropathy
Fei Tong
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Exenatide-loaded microsphere/ thermosensitive hydrogel long-acting delivery system with high drug bioactivity
Puxiu Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy
Wei Chen et al.
NATURE COMMUNICATIONS (2017)
Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation
Cuiwei Chen et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Insulin-loaded PLGA microspheres for glucose-responsive release
Jun-Zi Wu et al.
DRUG DELIVERY (2017)
Gold nanoparticles as an efficient drug delivery system for GLP-1 peptides
Magdalena Perez-Ortiz et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles
Javier O. Morales et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration of a GLP-1 Receptor Agonist
Eric L. Schneider et al.
ACS CHEMICAL BIOLOGY (2017)
Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery
Sergei Pechenov et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
GLP-1 and Amylin in the Treatment of Obesity
T. Jorsal et al.
CURRENT DIABETES REPORTS (2016)
Hydrogel Drug Delivery System Using Self-Cleaving Covalent Linkers for Once-a-Week Administration of Exenatide
Eric L. Schneider et al.
BIOCONJUGATE CHEMISTRY (2016)
Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation
Maria Yu et al.
CLINICAL THERAPEUTICS (2016)
Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery
Diane V. Doughty et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries
Roman Mathaes et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Comparative studies on exenatide-loaded poly (D,L-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying
Chune Zhu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Breaching the skin barrier through temperature modulations
Yasser Shahzad et al.
JOURNAL OF CONTROLLED RELEASE (2015)
A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components
Hanne M. Kinnunen et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Enhancing the Buccal Mucosal Delivery of Peptide and Protein Therapeutics
Thiago Caon et al.
PHARMACEUTICAL RESEARCH (2015)
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2015)
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Iqra Hameed et al.
WORLD JOURNAL OF DIABETES (2015)
Exploratory Trial of Intranasal Administration of Glucagon-Like Peptide-1 in Japanese Patients With Type 2 Diabetes
Hiroaki Ueno et al.
DIABETES CARE (2014)
Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
Ana Fortuna et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Subcutaneous Administration of Monoclonal Antibodies in Oncology
C. Jackisch et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2014)
Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site
Hanne M. Kinnunen et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Immunogenicity of therapeutic proteins: Influence of aggregation
Kirsty D. Ratanji et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Rapidly Dissolvable Microneedle Patches for Transdermal Delivery of Exenatide
Zhuangzhi Zhu et al.
PHARMACEUTICAL RESEARCH (2014)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
Victoria Divino et al.
DIABETES THERAPY (2014)
Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability
Feng Qi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
M. A. Nauck et al.
DIABETOLOGIA (2013)
Exenatide-loaded PLGA microspheres with improved glycemic control: In vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats
Jiming Xuan et al.
PEPTIDES (2013)
High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers
Edward T. Maggio et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
Wolfgang F. Richter et al.
AAPS JOURNAL (2012)
Microneedles for drug and vaccine delivery
Yeu-Chun Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
M. S. Fineman et al.
DIABETES OBESITY & METABOLISM (2012)
Nasal drug delivery - Recent developments and future prospects
Lisbeth Illum
JOURNAL OF CONTROLLED RELEASE (2012)
Encapsulation of Exenatide in Poly-(D,L-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
Mary Beth DeYoung et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes
M. T. Marino et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Liposomal formulations of glucagon-like peptide-1: Improved bioavailability and anti-diabetic effect
Junko Hanato et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils
Ivonne Olmedo et al.
BIOCONJUGATE CHEMISTRY (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
分享论文
